Fpn knockdown has been shown to increase the accumulation of iron-dependent lipid ROS to accelerate erastin-induced ferroptosis, and Fpn may be an appropriate target for NB treatment (113). The gene discussed is SLC40A1; the disease is neuroblastoma.